MedPath

albuterol sulfate

ALBUTEROL TABLETS USP

Approved
Approval ID

a22af54a-c010-ab8b-e053-2a95a90a8862

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 19, 2023

Manufacturers
FDA

Golden State Medical Supply

DUNS: 603184490

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

albuterol sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51407-367
Application NumberANDA072637
Product Classification
M
Marketing Category
C73584
G
Generic Name
albuterol sulfate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 19, 2023
FDA Product Classification

INGREDIENTS (5)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
ALBUTEROL SULFATEActive
Quantity: 2 mg in 1 1
Code: 021SEF3731
Classification: ACTIM
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

albuterol sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51407-368
Application NumberANDA072637
Product Classification
M
Marketing Category
C73584
G
Generic Name
albuterol sulfate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 19, 2023
FDA Product Classification

INGREDIENTS (5)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ALBUTEROL SULFATEActive
Quantity: 4 mg in 1 1
Code: 021SEF3731
Classification: ACTIM
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

albuterol sulfate - FDA Drug Approval Details